CANCER INST has a total of 21 patent applications. Its first patent ever was published in 1977. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology and pharmaceuticals are MEDIKINE INC, CHANGSHA QINCAI BIOTECHNOLOGY CO LTD and ASKGENE PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Australia | 1 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Nakamura Yusuke | 20 |
#2 | Emi Mitsuru | 4 |
#3 | Sato Takaaki | 4 |
#4 | Saito Hiroko | 3 |
#5 | Furukawa Yoichi | 3 |
#6 | Fujiwara Yoshiyuki | 3 |
#7 | Imai Takashi | 3 |
#8 | Martin Roger Francis | 1 |
Publication | Filing date | Title |
---|---|---|
EP0729975A1 | Ecdn protein and dna coding for the same | |
US5659016A | RPDL protein and DNA encoding the same | |
US5834245A | PRLTS proteins and DNA's encoding the same | |
US5559023A | Tumor suppressor gene | |
US5552526A | MDC proteins and DNAS encoding the same | |
EP0578909A1 | Human prohibitin and DNA coding for the same | |
AU3574378A | Cytotoxic agents |